Repligen Corp. (RGEN)

124.96 -3.78 (-2.93%) USD  |  NASDAQ  |  Mar 02, 16:00
124.96 0.00 (0.00%) After-Hours: 20:00
More

Repligen Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Orthofix Medical, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Abbott Laboratories Upgrade
Accuray, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade